Safety Alerts and Recalls

Safety Alerts & Recalls

Study Reveals Most Common Reasons for FDA Recalls

The five most common reasons for Food and Drug Administration (FDA)-issued recalls were contamination, mislabeling, adverse reaction, defective product, and incorrect potency, a new study has found.

Possible Lead Poisoning With Medicinal Clay, FDA Warns

The Food and Drug Administration (FDA) has warned against the use of Bentonite Me Baby by Alikay Naturals due to a potential lead poisoning risk.

Recall: Test Strips Falsely Report Low Glucose Readings

Arkray announced a recall of the SPOTCHEM II Basic PANEL-1 Reagent Test Strip and SPOTCHEM II Glucose Reagent Test Strip due to possible inaccurate blood sugar readings.

Recalled IV Solutions Found to Contain Cardboard, Dried Skin Fragments

Baxter announced a voluntary recall of 4 lots of intravenous (IV) solutions due to the potential for leaking containers and particulate matter.

OTC Cough Liquid Found to Contain Morphine

The Food and Drug Administration (FDA) is warning consumers to not use Licorice Coughing Liquid due to the presence of unidentified morphine.

Children's Cough Medicines Recalled Due to Incorrect Dosing Cups

Perrigo announced a voluntary recall to the retail level of 2 batches of its Children's Guaifenesin Grape Liquid (100mg per 5mL) and 3 batches of its Children's Guaifenesin DM Cherry Liquid (100mg/5mg per 5mL) supplied in 4oz bottles with dosage cups.

Seizure Drug Recalled Due To Potentially Incorrect Barcode

Hospira announced a voluntary recall of one lot of Magnesium Sulfate in Water for Injection (0.235mEq Mg/mL) 40mg/mL 2g total, 50mL due to a potentially incorrect barcode.

Insect Presence Found in IV Electrolytes, Hydration Products

Baxter announced a voluntary recall of 2 lots of 0.9% Sodium Chloride Injection, 250mL Viaflex Plastic Container and 70% Dextrose Injection, 2000mL, due to potential presence of particulate matter.

Dosing Errors with Antifungal Agent Prompt FDA to Issue Warning

The Food and Drug Administration (FDA) is cautioning that dosing errors for Noxafil (posaconazole) delayed-release tablets and oral suspension have resulted due to differences in dosing regimens between the two formulations.

FDA Orders Surgical Mesh Reclassification Due to Safety Concerns

The Food and Drug Administration (FDA) has issued 2 final orders to strengthen the data requirements for surgical mesh to repair pelvic organ prolapse (POP) transvaginally.